Which are the causes of Phyllodes tumor?

The exact cause of a Phyllodes tumor remains unknown, though it is understood to be a fibroepithelial neoplasm arising from the breast's connective tissue and glandular cells rather than a result of a singular environmental trigger.

Genetic Drivers of Phyllodes Tumor

Research into the etiology of a Phyllodes tumor indicates that it is driven by somatic genetic mutations—meaning changes that occur after birth within the tumor cells themselves, rather than being inherited from parents. The most frequently identified genetic alteration in these tumors is a mutation in the MED12 gene. Other genetic pathways often affected include TERT promoter mutations, RARA, and KMT2D. Think of these genes as the "instruction manuals" for cell growth; when these specific pages are corrupted, the cells begin to multiply uncontrollably, forming the characteristic leaf-like (phyllodes) structures for which the Phyllodes tumor is named.

Risk Factors vs. Causes

It is important to distinguish between a cause and a risk factor. A cause is the biological mechanism that triggers the disease, whereas a risk factor is a correlation that may increase the probability of development. While hormonal fluctuations (like estrogen exposure) are often discussed, there is no definitive evidence that they act as a direct cause of a Phyllodes tumor. Unlike common breast cancers, these tumors do not typically show a strong association with traditional lifestyle risk factors like diet or exercise. Currently, there is no evidence linking Phyllodes tumor to autoimmune, infectious, or metabolic processes.

Ongoing Research

The medical community is actively investigating why some tumors remain benign while others exhibit malignant potential. Current research focuses on genomic sequencing to better categorize the aggressive nature of a Phyllodes tumor, aiming to identify molecular markers that could predict recurrence. By mapping these genetic landscapes, researchers hope to move toward targeted therapies that could one day replace or augment surgical excision.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Phyllodes tumor


• Orphanet: Rare breast tumors


• National Cancer Institute (NCI): Phyllodes Tumor Treatment (PDQ®)